Skip to main content

Advertisement

SpringerLink
Log in

Cognitive performance of healthy young rats following chronic donepezil administration

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Experimental studies have investigated the effects of chronic donepezil treatment on the behavioral deficits elicited by reduced activity or the loss of cholinergic neurons that occurs in aging or in models of dementia. However, few studies have analyzed the effects of chronic donepezil treatment on the cognitive functions of intact animals.

Objectives

The cognitive functions of healthy young rats treated chronically with the acetylcholinesterase inhibitor donepezil were evaluated using a wide behavioral test battery.

Results

Chronic treatment with donepezil ameliorated memory functions and explorative strategies, speeded up the acquisition of localizing knowledge, augmented responsiveness to the context, and reduced anxiety levels. However, it did not affect spatial span, modify motivational levels, or influence associative learning.

Conclusions

The present findings show the specific profile of donepezil action on cognitive functions in the presence of unaltered cholinergic neurotransmission systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL (2000) Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99:17–23

    Article  PubMed  CAS  Google Scholar 

  • Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495–529

    Article  PubMed  CAS  Google Scholar 

  • Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 30:408–414

    Article  Google Scholar 

  • Birks J, Flicker L (2006) Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 193:CD006104

    Google Scholar 

  • Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F (2003) Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacology 28:1235–1246

    Article  PubMed  CAS  Google Scholar 

  • Carey GJ, Billard W, Binch H 3rd, Cohen-Williams M, Crosby G, Grzelak M, Guzik H, Kozlowski JA, Lowe DB, Pond AJ, Tedesco RP, Watkins RW, Coffin VL (2001) SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. Eur J Pharmacol 431:189–200

    Article  PubMed  CAS  Google Scholar 

  • Cheng DH, Ren H, Tang XC (1996) Huperzine a novel promising acetylcholinesterase inhibitor. Neuroreport 8:97–101

    Article  PubMed  CAS  Google Scholar 

  • Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS (1978) Physostigmine: improvement of long-term memory processes in normal humans. Science 201:272–274

    Article  PubMed  CAS  Google Scholar 

  • Dawson GR, Iversen SD (1993) The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav Brain Res 57:143–153

    Article  PubMed  CAS  Google Scholar 

  • Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG (2005) Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease. Psychopharmacology 181:145–152

    Article  PubMed  CAS  Google Scholar 

  • Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED (2001) Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A 98:4728–4733

    Article  PubMed  CAS  Google Scholar 

  • Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649–684

    Article  PubMed  CAS  Google Scholar 

  • Federico F, Leggio MG, Neri P, Mandolesi L, Petrosini L (2006) NMDA receptor activity in learning spatial procedural strategies II. The influence of cerebellar lesions. Brain Res Bull 16:356–367

    Article  CAS  Google Scholar 

  • Freo U, Pizzolato G, Dam M, Ori C, Battistin L (2002) A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J Neural Transm 109:857–870

    Article  PubMed  CAS  Google Scholar 

  • Furey ML, Pietrini P, Haxby JV (2000) Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290:2315–2319

    Article  PubMed  CAS  Google Scholar 

  • Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B, Donepezil MSAD Study Investigators Group (2002a) Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer’s disease. Int Psychogeriatr 14:389–404

    Article  PubMed  Google Scholar 

  • Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P, Donepezil MSAD Study Investigators’ Group (2002b) Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer’s disease. Curr Med Res Opin 18:347–354

    Article  PubMed  CAS  Google Scholar 

  • Giacobini E, Zhu XD, Williams E, Sherman KA (1996) The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex. Neuropharmacology 35:205–211

    Article  PubMed  CAS  Google Scholar 

  • Gill TM, Sarter M, Givens B (2000) Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J Neurosci 20:4745–4757

    PubMed  CAS  Google Scholar 

  • Giovannini MG, Casamenti F, Bartolini L, Pepeu G (1997) The brain cholinergic system as a target of cognition enhancers. Behav Brain Res 83:1–5

    Article  PubMed  CAS  Google Scholar 

  • Gold PE (2003) Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80:194–210

    Article  PubMed  CAS  Google Scholar 

  • Grön G, Kirstein M, Thielscher A, Riepe MW, Spitzer M (2005) Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology 182:170–179

    Article  PubMed  CAS  Google Scholar 

  • Hatip-Al-Khatib I, Iwasaki K, Yoshimitsu Y, Arai T, Egashira N, Mishima K, Ikeda T, Fujiwara M (2005) Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats. Br J Pharmacol 145:1035–44

    Article  PubMed  CAS  Google Scholar 

  • Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL, Terry AV (2006) Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. J Pharmacol Exp Ther 316:679–694

    Article  PubMed  CAS  Google Scholar 

  • Higgins GA, Enderlin M, Fimbel R, Haman M, Grottick AJ, Soriano M, Richards JG, Kemp JA, Gill R (2002) Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. Eur J Neurosci 15:1827–1840

    Article  PubMed  CAS  Google Scholar 

  • Kirkby DL, Jones DN, Barnes JC, Higgins GA (1996) Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function. Behav Pharmacol l7:513–525

    Google Scholar 

  • Kumari V, Gray JA, ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T (2003) Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 19:1002–1013

    Article  PubMed  Google Scholar 

  • Leggio MG, Federico F, Neri P, Graziano A, Mandolesi L, Petrosini L (2006) NMDA receptor activity in learning spatial procedural strategies. I. The influence of hippocampal lesions. Brain Res Bull 16:347–355

    Article  CAS  Google Scholar 

  • Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217–30

    Article  PubMed  CAS  Google Scholar 

  • Levy ML, Cummings JL, Kahn-Rose R (1999) Neuropsychiatric symptoms and cholinergic therapy for Alzheimer’s disease. Gerontology 45:15–22

    Article  PubMed  CAS  Google Scholar 

  • Liang YQ, Tang XC (2006) Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta Pharmacol Sin 27:1127–36

    Article  PubMed  CAS  Google Scholar 

  • Mandolesi L, Leggio MG, Graziano A, Neri P, Petrosini L (2001) Cerebellar contribution to spatial event processing: involvement in procedural and working memory components. Eur J Neurosci 14:2011–2022

    Article  PubMed  CAS  Google Scholar 

  • Molinari M, Grammaldo LG, Petrosini L (1997) Cerebellar contribution to spatial event processing: right/left discrimination abilities in rats. Eur J Neurosci 9:1986–1992

    Article  PubMed  CAS  Google Scholar 

  • Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T (2005) Modulation of N-methyl-d-aspartate receptors by donepezil in rat cortical neurons. J Pharmacol Exp Ther 315:125–135

    Article  PubMed  CAS  Google Scholar 

  • Morris RG, Garrud P, Rawlins JN, O’Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683

    Article  PubMed  CAS  Google Scholar 

  • Mumenthaler MS, Yesavage JA, Taylor JL, O’Hara R, Friedman L, Lee H, Kraemer HC (2003) Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacology. 28:1366–1373

    Article  PubMed  CAS  Google Scholar 

  • Narahashi T, Moriguchi S, Zhao X, Marszalec W, Yeh JZ (2004) Mechanisms of action of cognitive enhancers on neuroreceptors. Biol Pharm Bull 27:1701–1706

    Article  PubMed  CAS  Google Scholar 

  • Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find Exp Clin Pharmacol 22:89–95

    Article  PubMed  CAS  Google Scholar 

  • Palmer AM (2002) Pharmacotherapy for Alzheimer’s disease: progress and prospects. Trends Pharmacol Sci 23:426–433

    Article  PubMed  CAS  Google Scholar 

  • Parent MB, Baxter MG (2004) Septohippocampal acetylcholine: involved in but not necessary for learning and memory? Learn Mem 11:9–20

    Article  PubMed  Google Scholar 

  • Pepeu G, Giovannini MG (2004) Changes in acetylcholine extracellular levels during cognitive processes. Learn Mem 11:21–27

    Article  PubMed  Google Scholar 

  • Petrosini L, Molinari M, Dell’Anna ME (1996) Cerebellar contribution to spatial event processing: Morris water maze and T-maze. Eur J Neurosci 8:1882–1896

    Article  PubMed  CAS  Google Scholar 

  • Phillis JW (2005) Acetylcholine release from the central nervous system: a 50-year retrospective. Crit Rev Neurobiol 17:161–217

    PubMed  CAS  Google Scholar 

  • Poorheidari G, Stanhope KJ, Pratt JA (1998) Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020. Psychopharmacology 135:242–255

    Article  PubMed  CAS  Google Scholar 

  • Prickaerts J, Sik A, van der Staay FJ, de Vente J, Blokland A (2005) Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation. Psychopharmacology 177:381–390

    Article  PubMed  CAS  Google Scholar 

  • Rogers SL, Friedhoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia 7:293–303

    Article  PubMed  CAS  Google Scholar 

  • Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 158:1021–1031

    Article  PubMed  CAS  Google Scholar 

  • Rose SP (2002) ‘Smart drugs’: do they work? Are they ethical? Will they be legal? Nat Rev Neurosci 3:975–979

    Article  PubMed  CAS  Google Scholar 

  • Rupniak NM, Tye SJ, Field MJ (1997) Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys. Psychopharmacology 131:406–410

    Article  PubMed  CAS  Google Scholar 

  • Sarter M, Givens B, Bruno JP (2001) The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Rev 35:146–160

    Article  PubMed  CAS  Google Scholar 

  • Sarter M, Bruno JP, Givens B (2003) Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Mem 80:245–256

    Article  PubMed  CAS  Google Scholar 

  • Saykin AJ, Wishart HA, Rabin LA, Flashman LA, McHugh TL, Mamourian AC, Santulli RB (2004) Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127:1574–1583

    Article  PubMed  Google Scholar 

  • Seltzer B (2007) Donepezil: an update. Expert Opin Pharmacother 8:1011–1023

    Article  PubMed  CAS  Google Scholar 

  • Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A (2006) Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. Brain Res Bull 9:204–213

    Article  CAS  Google Scholar 

  • Shigeta M, Homma A (2001) Donepezil for Alzheimer’s disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev 7:353–368

    Article  PubMed  CAS  Google Scholar 

  • Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1–14

    Article  PubMed  CAS  Google Scholar 

  • Spowart-Manning L, van der Staay FJ (2004) The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse. Behav Brain Res 151:37–46

    Article  PubMed  CAS  Google Scholar 

  • Spowart-Manning L, van der Staay FJ (2005) Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task. Behav Brain Res 156:269–276

    Article  PubMed  CAS  Google Scholar 

  • Sugimoto H (2001) Donepezil hydrochloride: a treatment drug for Alzheimer’s disease. Chem Rec 1:63–73

    Article  PubMed  CAS  Google Scholar 

  • Sun QQ, Xu SS, Pan JL, Guo HM, Cao WQ (1999) Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Zhongguo Yao Li Xue Bao 20:601–603

    PubMed  CAS  Google Scholar 

  • Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A (2003) Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306:772–777

    Article  PubMed  CAS  Google Scholar 

  • Tokita K, Yamazaki S, Yamazaki M, Matsuoka N, Mutoh S (2002) Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats. Pharmacol Biochem Behav 73:511–519

    Article  PubMed  CAS  Google Scholar 

  • van der Staay FJ, Bouger PC (2005) Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats. Behav Brain Res 156:1–10

    Article  PubMed  CAS  Google Scholar 

  • Winstein CJ, Bentzen KR, Boyd L, Schneider LS (2007) Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer’s disease? Curr Alzheimer Res 4:273–276

    Article  PubMed  CAS  Google Scholar 

  • Wise LE, Iredale PA, Stokes RJ, Lichtman AH (2007) Combination of rimonabant and donepezil prolongs spatial memory duration. Neuropsychopharmacology 32:1805–1812

    Article  PubMed  CAS  Google Scholar 

  • Yamada K, Takayanagi M, Kamei H, Nagai T, Dohniwa M, Kobayashi K, Yoshida S, Ohhara T, Takuma K, Nabeshima T (2005) Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed-matching to position task in rats. Behav Brain Res 162:191–199

    Article  PubMed  CAS  Google Scholar 

  • Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O’Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ (2002) Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59:123–125

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Zhou FM, Dani JA (2004) Cholinergic drugs for Alzheimer’s disease enhance in vitro dopamine release. Mol Pharmacol 66:538–544

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Donepezil was generously gifted by Eisai, Inc. This study was supported by MIUR grants to LP. None of the authors has a conflict of interest.

Conflict of interest statement

None of the authors has any conflict of interest.

Author information

Authors and Affiliations

  1. IRCCS Santa Lucia Foundation, Rome, Italy

    Debora Cutuli, Francesca Foti, Laura Mandolesi, Paola De Bartolo, Francesca Gelfo, Francesca Federico & Laura Petrosini

  2. University of Naples “Parthenope”, Naples, Italy

    Laura Mandolesi & Francesca Gelfo

  3. Department of Psychology, University of Rome “La Sapienza”, Via dei Marsi 78, 00185, Rome, Italy

    Debora Cutuli, Francesca Foti, Paola De Bartolo & Laura Petrosini

  4. University of Siena, Siena, Italy

    Francesca Federico

Authors
  1. Debora Cutuli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Foti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Mandolesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paola De Bartolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesca Gelfo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesca Federico
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laura Petrosini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Petrosini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cutuli, D., Foti, F., Mandolesi, L. et al. Cognitive performance of healthy young rats following chronic donepezil administration. Psychopharmacology 197, 661–673 (2008). https://doi.org/10.1007/s00213-008-1084-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-008-1084-0

Keywords

Search

Navigation